BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2025 2:50:53 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-10-15 02:17 |
|
Peer-Review Started |
|
2025-10-15 02:17 |
|
First Decision by Editorial Office Director |
|
2025-10-21 09:36 |
|
Return for Revision |
|
2025-10-21 09:36 |
|
Revised |
|
2025-10-28 13:01 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-12 02:49 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-12 11:03 |
|
Articles in Press |
|
2025-11-12 11:03 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-16 01:36 |
|
Publish the Manuscript Online |
|
2025-12-27 02:50 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pathology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Unmasking the high-risk phenotype in autoimmune gastritis: A pathologist’s roadmap for the clinician
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Cheng-Long Wang, Min Zeng and Yan Luo |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chongqing Health Commission and Science and Technology Bureau |
No. 2023MSXM060 |
|
| Corresponding Author |
Yan Luo, MD, Department of Stomatology, The People’s Hospital of Dadukou District, No. 102 Cuibai Road, Dadukou District, Chongqing 400084, China. luokate88@gmail.com |
| Key Words |
Pathology; Autoimmune gastritis; Gastric neuroendocrine tumors; Precursor lesions; Dysplasia |
| Core Tip |
Clinical risk models identify patients with autoimmune gastritis who may develop neuroendocrine tumors, but pathology guides what to do next. We advocate for a “prognostic biopsy protocol” where pathologists report the specific stage of microscopic pre-cancerous lesions. Finding high-risk changes, especially dysplasia, serves as a clear trigger to intensify surveillance. This approach allows clinicians to manage risk proactively based on a patient’s real-time biology, rather than waiting for a visible tumor to develop. |
| Publish Date |
2025-12-27 02:50 |
| Citation |
Wang CL, Zeng M, Luo Y. Unmasking the high-risk phenotype in autoimmune gastritis: A pathologist’s roadmap for the clinician. World J Gastroenterol 2025; 31(48): 115244 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i48/115244.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i48.115244 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
